Introduced at this year's International Society on Thrombosis and Haemostasis (ISTH) and American Association for Clinical Chemistry (AACC) conferences in July, IL plans to fully commercialize the ACL TOP 700 and ACL TOP 700 CTS Hemostasis Testing Systems later this year. These instruments will give IL an even more extensive product offering for semi-automated to fully automated hemostasis laboratories.
Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM® product offerings, part of the critical care line, include the new GEM Premier 3500 with Intelligent Quality Management (iQM®), GEM Premier(TM) 4000 analyzer, GEMweb Plus information management system, and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP®( )Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP, the new ACL TOP LAS and the ACL TOP 500 CTS. IL also offers the new ACL AcuStar(TM), ACL ELITE® and ELITE PRO, other hemostasis analyzers and the HemosIL® line of reagents. IL is based in Bedford, Massachusetts.
The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL TOP, ACL ELITE, ACL AcuStar and Premier are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and
|SOURCE Instrumentation Laboratory|
Copyright©2009 PR Newswire.
All rights reserved